AA
RETA

AlphaMark Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

AlphaMark Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-115
Closed -$11K – 521
2019
Q2 		$11K Hold
115
– – ﹤0.01% 327
2019
Q1 		$10K Hold
115
– – ﹤0.01% 329
2018
Q4 		$6K Hold
115
– – ﹤0.01% 366
2018
Q3 		$9K Buy
+115
New +$9K ﹤0.01% 364